CC vs TMO · P/E 72, rev $1.36B vs P/E 24, rev $44.56B
Chemours Co (CC) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Chemours Co (CC) is a specialty chemicals company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported CC revenue for 2024-12-31 was $1.36B. Net income was -$8.0M. Revenue was down 9.9% from 2024-09-30 to 2024-12-31. CC currently screens at market cap $1.94B and trailing P/E 71.8.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
CC currently screens at market cap $1.94B and trailing P/E 71.8. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the CC and TMO stock pages for the full models.
Not investment advice.